1. Home
  2. ENSC vs BAOS Comparison

ENSC vs BAOS Comparison

Compare ENSC & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • BAOS
  • Stock Information
  • Founded
  • ENSC 2003
  • BAOS 2018
  • Country
  • ENSC United States
  • BAOS China
  • Employees
  • ENSC N/A
  • BAOS N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • ENSC Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • ENSC Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • ENSC 3.4M
  • BAOS 3.4M
  • IPO Year
  • ENSC N/A
  • BAOS 2021
  • Fundamental
  • Price
  • ENSC $2.38
  • BAOS $3.76
  • Analyst Decision
  • ENSC
  • BAOS
  • Analyst Count
  • ENSC 0
  • BAOS 0
  • Target Price
  • ENSC N/A
  • BAOS N/A
  • AVG Volume (30 Days)
  • ENSC 455.1K
  • BAOS 4.1M
  • Earning Date
  • ENSC 05-13-2025
  • BAOS 06-17-2025
  • Dividend Yield
  • ENSC N/A
  • BAOS N/A
  • EPS Growth
  • ENSC N/A
  • BAOS N/A
  • EPS
  • ENSC N/A
  • BAOS N/A
  • Revenue
  • ENSC $6,224,081.00
  • BAOS $624,087.00
  • Revenue This Year
  • ENSC N/A
  • BAOS N/A
  • Revenue Next Year
  • ENSC $1,381.48
  • BAOS N/A
  • P/E Ratio
  • ENSC N/A
  • BAOS N/A
  • Revenue Growth
  • ENSC 256.35
  • BAOS N/A
  • 52 Week Low
  • ENSC $1.62
  • BAOS $1.44
  • 52 Week High
  • ENSC $14.67
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 49.99
  • BAOS 74.48
  • Support Level
  • ENSC $2.12
  • BAOS $2.27
  • Resistance Level
  • ENSC $2.57
  • BAOS $4.39
  • Average True Range (ATR)
  • ENSC 0.21
  • BAOS 0.33
  • MACD
  • ENSC 0.04
  • BAOS 0.16
  • Stochastic Oscillator
  • ENSC 53.87
  • BAOS 71.23

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: